Form 4: Akoya Biosciences CFO John Frederick Ek Reports Stock Transaction
Sentiment:
SEC Form 4 Filing
CFO of Akoya Biosciences, John Frederick Ek, reports disposition of shares to cover taxes on a restricted stock unit award.
Summary
- John Frederick Ek, CFO of Akoya Biosciences, reported a transaction on April 1, 2024.
- 14,272 shares of common stock were disposed of to cover taxes related to a restricted stock unit award.
- The price per share for the transaction was $4.56.
- Following the transaction, Ek directly owns 180,728 shares of common stock.
- Ek also indirectly owns 20,000 shares through the Ek Trust Dated November 20, 2020.
Sentiment
Score: 5
Explanation: This is a routine Form 4 filing related to tax obligations on vested stock, indicating a neutral sentiment.
Key Dates
| Date | Description |
|---|---|
| November 20, 2020 | Date of the Ek Trust |
| March 20, 2023 | Date of the restricted stock unit award grant |
| April 1, 2024 | Date of the stock transaction (disposal of shares) |
| April 1, 2024 | Vesting start date of the restricted stock unit award |
| April 2, 2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.